vs
GDEV Inc.（GDEV）与SOLENO THERAPEUTICS INC（SLNO）财务数据对比。点击上方公司名可切换其他公司
GDEV Inc.的季度营收约是SOLENO THERAPEUTICS INC的1.8倍（$119.9M vs $66.0M），SOLENO THERAPEUTICS INC净利率更高（39.4% vs 13.9%，领先25.5%）
GDEV Inc.是一家游戏娱乐控股公司，在纳斯达克上市，总部位于塞浦路斯利马索尔。该公司前身为2014年成立的游戏公司Nexters，2023年6月改组为控股集团，是欧洲前五的独立移动游戏企业，旗下拥有Nexters Studio、Cubic Games、Royal Ark、Game Gears、Light Hour Games等工作室，分支机构分布在塞浦路斯、亚美尼亚、哈萨克斯坦等地。
索雷诺治疗是一家临床阶段生物制药企业，专注于开发针对罕见内分泌、代谢及神经发育疾病的创新疗法，核心在研药物用于治疗普拉德-威利综合征，服务覆盖北美、欧盟等地区的罕见病患者群体。
GDEV vs SLNO — 直观对比
营收规模更大
GDEV
是对方的1.8倍
$66.0M
净利率更高
SLNO
高出25.5%
13.9%
损益表 — Q2 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $119.9M | $66.0M |
| 净利润 | $16.6M | $26.0M |
| 毛利率 | — | 98.3% |
| 营业利润率 | 15.5% | 33.5% |
| 净利率 | 13.9% | 39.4% |
| 营收同比 | 13.3% | — |
| 净利润同比 | 13.0% | 134.0% |
| 每股收益（稀释后） | $0.90 | $0.47 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GDEVSLNO
| Q3 25 | — | $66.0M | ||
| Q2 25 | $119.9M | $32.7M | ||
| Q2 24 | $105.8M | — | ||
| Q2 23 | $114.9M | — | ||
| Q2 22 | $125.8M | — |
净利润GDEVSLNO
| Q3 25 | — | $26.0M | ||
| Q2 25 | $16.6M | $-4.7M | ||
| Q2 24 | $14.7M | — | ||
| Q2 23 | $19.5M | — | ||
| Q2 22 | $29.3M | — |
毛利率GDEVSLNO
| Q3 25 | — | 98.3% | ||
| Q2 25 | — | 97.9% | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — | ||
| Q2 22 | — | — |
营业利润率GDEVSLNO
| Q3 25 | — | 33.5% | ||
| Q2 25 | 15.5% | -20.0% | ||
| Q2 24 | 14.4% | — | ||
| Q2 23 | 12.9% | — | ||
| Q2 22 | 34.4% | — |
净利率GDEVSLNO
| Q3 25 | — | 39.4% | ||
| Q2 25 | 13.9% | -14.4% | ||
| Q2 24 | 13.9% | — | ||
| Q2 23 | 17.0% | — | ||
| Q2 22 | 23.3% | — |
每股收益（稀释后）GDEVSLNO
| Q3 25 | — | $0.47 | ||
| Q2 25 | $0.90 | $-0.09 | ||
| Q2 24 | $0.81 | — | ||
| Q2 23 | $0.99 | — | ||
| Q2 22 | $0.15 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $41.6M | $498.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-129.4M | $494.8M |
| 总资产 | $210.2M | $599.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资GDEVSLNO
| Q3 25 | — | $498.9M | ||
| Q2 25 | $41.6M | $286.8M | ||
| Q2 24 | $50.8M | — | ||
| Q2 23 | $68.6M | — | ||
| Q2 22 | $91.4M | — |
股东权益GDEVSLNO
| Q3 25 | — | $494.8M | ||
| Q2 25 | $-129.4M | $240.1M | ||
| Q2 24 | $-118.7M | — | ||
| Q2 23 | $-135.8M | — | ||
| Q2 22 | $-105.2M | — |
总资产GDEVSLNO
| Q3 25 | — | $599.9M | ||
| Q2 25 | $210.2M | $332.3M | ||
| Q2 24 | $282.8M | — | ||
| Q2 23 | $302.2M | — | ||
| Q2 22 | $373.3M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $43.5M |
| 自由现金流经营现金流 - 资本支出 | — | $43.5M |
| 自由现金流率自由现金流/营收 | — | 65.8% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | 1.67× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流GDEVSLNO
| Q3 25 | — | $43.5M | ||
| Q2 25 | — | $-12.6M | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — | ||
| Q2 22 | $21.1M | — |
自由现金流GDEVSLNO
| Q3 25 | — | $43.5M | ||
| Q2 25 | — | $-12.6M | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — | ||
| Q2 22 | — | — |
自由现金流率GDEVSLNO
| Q3 25 | — | 65.8% | ||
| Q2 25 | — | -38.6% | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — | ||
| Q2 22 | — | — |
资本支出强度GDEVSLNO
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — | ||
| Q2 22 | — | — |
现金转化率GDEVSLNO
| Q3 25 | — | 1.67× | ||
| Q2 25 | — | — | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — | ||
| Q2 22 | 0.72× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
